Victor Chi

Victor Chi is an Associate Director at Calibr, a division of Scripps Research, where they currently lead efforts in drug discovery. They possess a strong pharmaceutical science background, focusing on small molecule and peptide therapeutics, and have extensive experience in various assays and laboratory technologies. Victor earned a PhD in Biomedical Sciences from the University of California, Irvine, where they characterized the pharmacokinetic-pharmacodynamic relationship of a therapeutic peptide for autoimmune disorders. Prior to their current role, they served as a Senior Associate Scientist at Amgen, establishing critical metabolism assays.